##ANALYSISTYPE=GERMLINE_TRIO
##PIPELINE=megSAP 0.1-801-g5514c2e
##SAMPLE=<ID=GS140550_01,Gender=male,ExternalSampleName=131751,IsTumor=no,IsFFPE=no,DiseaseGroup=n/a,DiseaseStatus=control>
##SAMPLE=<ID=GS140549_01,Gender=female,ExternalSampleName=131752,IsTumor=no,IsFFPE=no,DiseaseGroup=n/a,DiseaseStatus=control>
##SAMPLE=<ID=GS140127_01,Gender=male,ExternalSampleName=131787,IsTumor=no,IsFFPE=no,DiseaseGroup=n/a,DiseaseStatus=affected>
##DESCRIPTION=GS140550_01=genotype of sample GS140550_01
##DESCRIPTION=GS140549_01=genotype of sample GS140549_01
##DESCRIPTION=GS140127_01=genotype of sample GS140127_01
##DESCRIPTION=filter=Annotations for filtering and ranking variants.
##DESCRIPTION=quality=Quality parameters - SNP quality (QUAL), depth (DP), allele frequency (AF), mean mapping quality of alternate allele (MQM).
##DESCRIPTION=gene=Affected gene list (comma-separated).
##DESCRIPTION=variant_type=Variant type.
##DESCRIPTION=coding_and_splicing=Coding and splicing details (Gene, ENST number, type, impact, exon/intron number, HGVS.c, HGVS.p, Pfam domain).
##DESCRIPTION=RepeatMasker=RepeatMasker annotation.
##DESCRIPTION=dbSNP=Identifier in dbSNP database.
##DESCRIPTION=1000g=Allele frequency in 1000 genomes project.
##DESCRIPTION=gnomAD=Allele frequency in gnomAD project.
##DESCRIPTION=gnomAD_hom_hemi=Homoyzgous counts and hemizygous counts of gnomAD project (genome data).
##DESCRIPTION=gnomAD_sub=Sub-population allele frequenciens (AFR,AMR,EAS,NFE,SAS) in gnomAD project.
##DESCRIPTION=ESP_sub=Sub-population allele frequency (EA,AA) in NHLBI Exome Sequencing project.
##DESCRIPTION=phyloP=phyloP (100way vertebrate) annotation. Deleterious threshold > 1.6.
##DESCRIPTION=Sift=Sift effect prediction for each transcript: D=damaging, T=tolerated.
##DESCRIPTION=PolyPhen=PolyPhen (humVar) effect prediction for each transcript: D=probably damaging, P=possibly damaging, B=benign.
##DESCRIPTION=fathmm-MKL=fathmm-MKL score (for coding/non-coding regions). Deleterious threshold > 0.5.
##DESCRIPTION=CADD=CADD pathogenicity prediction scores (scaled phred-like). Deleterious threshold > 15-20.
##DESCRIPTION=REVEL=REVEL pathogenicity prediction score. Deleterious threshold > 0.5.
##DESCRIPTION=OMIM=OMIM database annotation.
##DESCRIPTION=ClinVar=ClinVar database annotation.
##DESCRIPTION=HGMD=HGMD database annotation.
##DESCRIPTION=COSMIC=COSMIC somatic variant database anntotation.
##DESCRIPTION=NGSD_hom=Homozygous variant counts in NGSD independent of the processing system.
##DESCRIPTION=NGSD_het=Heterozygous variant counts in NGSD independent of the processing system.
##DESCRIPTION=classification=Classification from the NGSD.
##DESCRIPTION=classification_comment=Classification comment from the NGSD.
##DESCRIPTION=validation=Validation information from the NGSD. Validation results of other samples are listed in brackets!
##DESCRIPTION=comment=Variant comments from the NGSD.
##DESCRIPTION=gene_info=Gene information from NGSD (inheritance mode, ExAC pLI score).
##FILTER=gene_blacklist=The gene(s) are contained on the blacklist of unreliable genes.
##FILTER=off-target=Variant marked as 'off-target'.
#chr	start	end	ref	obs	GS140550_01	GS140549_01	GS140127_01	filter	quality	gene	variant_type	coding_and_splicing	RepeatMasker	dbSNP	1000g	gnomAD	gnomAD_hom_hemi	gnomAD_sub	ESP_sub	phyloP	Sift	PolyPhen	fathmm-MKL	CADD	REVEL	OMIM	ClinVar	HGMD	COSMIC	NGSD_hom	NGSD_het	classification	classification_comment	validation	comment	gene_info
chr8	144989452	144989452	T	C	het	wt	het	gene_blacklist	QUAL=1204;DP=66,53,21;AF=0.56,0.00,0.52;MQM=60	PLEC	3'UTR	PLEC:ENST00000322810:3_prime_UTR_variant:MODIFIER:exon32/32:c.*893A>G::,PLEC:ENST00000345136:3_prime_UTR_variant:MODIFIER:exon32/32:c.*893A>G::,PLEC:ENST00000354589:3_prime_UTR_variant:MODIFIER:exon32/32:c.*893A>G::,PLEC:ENST00000354958:3_prime_UTR_variant:MODIFIER:exon32/32:c.*893A>G::,PLEC:ENST00000356346:3_prime_UTR_variant:MODIFIER:exon32/32:c.*893A>G::,PLEC:ENST00000357649:3_prime_UTR_variant:MODIFIER:exon32/32:c.*893A>G::,PLEC:ENST00000398774:3_prime_UTR_variant:MODIFIER:exon32/32:c.*893A>G::,PLEC:ENST00000436759:3_prime_UTR_variant:MODIFIER:exon33/33:c.*893A>G::		rs189205952	0.0006	0.0005				0.5610			0.69,0.91	1.46		601282 [PLEC (confirmed) Epidermolysis bullosa simplex with muscular dystrophy,226670/Epidermolysis bullosa simplex,Ogna type,131950/Epidermolysis bullosa simplex with pyloric atresia,612138/Muscular dystrophy,limb-girdle,type 2Q,613723/Epidermolysis bullosa simplex with nail dystrophy,616487];				0	2					PLEC (inh=AR+AD pLI=0.04)
chr8	145024450	145024450	C	T	wt	het	het	gene_blacklist	QUAL=4590;DP=329,261,98;AF=0.00,0.54,0.52;MQM=60	PLEC	missense,intron	PLEC:ENST00000322810:missense_variant:MODERATE:exon1/32:c.425G>A:p.Arg142Gln:,PLEC:ENST00000354958:intron_variant:MODIFIER:exon1/31:c.46+3444G>A::,PLEC:ENST00000356346:intron_variant:MODIFIER:exon1/31:c.71-11590G>A::,PLEC:ENST00000436759:intron_variant:MODIFIER:exon2/32:c.194-11590G>A::,PLEC:ENST00000527096:intron_variant:MODIFIER:exon1/31:c.194-11590G>A::		rs558227477		0.0001		0.0000,0.0001,0.0000,0.0000,0.0001		2.5160	D, , , , 	B, , , , 	0.08,0.81	3.18	0.15	601282 [PLEC (confirmed) Epidermolysis bullosa simplex with muscular dystrophy,226670/Epidermolysis bullosa simplex,Ogna type,131950/Epidermolysis bullosa simplex with pyloric atresia,612138/Muscular dystrophy,limb-girdle,type 2Q,613723/Epidermolysis bullosa simplex with nail dystrophy,616487];				0	2					PLEC (inh=AR+AD pLI=0.04)
chr17	62006129	62006129	-	G	het	wt	het		QUAL=934;DP=37,34,59;AF=0.54,0.00,0.49;MQM=60	CD79B	3'UTR	CD79B:ENST00000006750:3_prime_UTR_variant:MODIFIER:exon6/6:c.*456dup::,CD79B:ENST00000392795:3_prime_UTR_variant:MODIFIER:exon6/6:c.*456dup::		rs554643850	0.0014	0.0051								-0.14		147245 [CD79B (provisional) Agammaglobulinemia 6,612692];				0	3					CD79B (inh=AR pLI=0.94)
chr17	62006406	62006406	A	G	wt	het	het		QUAL=1802;DP=127,64,96;AF=0.00,0.45,0.48;MQM=60	CD79B	3'UTR	CD79B:ENST00000006750:3_prime_UTR_variant:MODIFIER:exon6/6:c.*180T>C::,CD79B:ENST00000392795:3_prime_UTR_variant:MODIFIER:exon6/6:c.*180T>C::		rs147717759	0.0030	0.0060				-0.6640			0.01,0.13	0.06		147245 [CD79B (provisional) Agammaglobulinemia 6,612692];				0	7					CD79B (inh=AR pLI=0.94)
